1
|
Morris AT, Temereanca S, Zandvakili A, Thorpe R, Sliva DD, Greenberg BD, Carpenter LL, Philip NS, Jones SR. Fronto-central resting-state 15-29 Hz transient beta events change with therapeutic transcranial magnetic stimulation for posttraumatic stress disorder and major depressive disorder. Sci Rep 2023; 13:6366. [PMID: 37076496 PMCID: PMC10115889 DOI: 10.1038/s41598-023-32801-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Accepted: 04/03/2023] [Indexed: 04/21/2023] Open
Abstract
Repetitive transcranial magnetic stimulation (rTMS) is an established treatment for major depressive disorder (MDD) and shows promise for posttraumatic stress disorder (PTSD), yet effectiveness varies. Electroencephalography (EEG) can identify rTMS-associated brain changes. EEG oscillations are often examined using averaging approaches that mask finer time-scale dynamics. Recent advances show some brain oscillations emerge as transient increases in power, a phenomenon termed "Spectral Events," and that event characteristics correspond with cognitive functions. We applied Spectral Event analyses to identify potential EEG biomarkers of effective rTMS treatment. Resting 8-electrode EEG was collected from 23 patients with MDD and PTSD before and after 5 Hz rTMS targeting the left dorsolateral prefrontal cortex. Using an open-source toolbox ( https://github.com/jonescompneurolab/SpectralEvents ), we quantified event features and tested for treatment associated changes. Spectral Events in delta/theta (1-6 Hz), alpha (7-14 Hz), and beta (15-29 Hz) bands occurred in all patients. rTMS-induced improvement in comorbid MDD PTSD were associated with pre- to post-treatment changes in fronto-central electrode beta event features, including frontal beta event frequency spans and durations, and central beta event maxima power. Furthermore, frontal pre-treatment beta event duration correlated negatively with MDD symptom improvement. Beta events may provide new biomarkers of clinical response and advance the understanding of rTMS.
Collapse
Affiliation(s)
- Alexander T Morris
- VA RR&D Center for Neurorestoration and Neurotechnology, VA Providence, Providence, RI, USA
| | - Simona Temereanca
- VA RR&D Center for Neurorestoration and Neurotechnology, VA Providence, Providence, RI, USA.
- Department of Neuroscience, Brown University, Providence, RI, USA.
- Carney Institute for Brain Science, Brown University, Providence, RI, USA.
| | - Amin Zandvakili
- VA RR&D Center for Neurorestoration and Neurotechnology, VA Providence, Providence, RI, USA
- Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA
| | - Ryan Thorpe
- Department of Neuroscience, Brown University, Providence, RI, USA
- Carney Institute for Brain Science, Brown University, Providence, RI, USA
| | - Danielle D Sliva
- Department of Neuroscience, Brown University, Providence, RI, USA
- Carney Institute for Brain Science, Brown University, Providence, RI, USA
| | - Benjamin D Greenberg
- VA RR&D Center for Neurorestoration and Neurotechnology, VA Providence, Providence, RI, USA
- Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA
- COBRE Center for Neuromodulation, Butler Hospital, Providence, RI, USA
| | - Linda L Carpenter
- Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA
- COBRE Center for Neuromodulation, Butler Hospital, Providence, RI, USA
- Carney Institute for Brain Science, Brown University, Providence, RI, USA
| | - Noah S Philip
- VA RR&D Center for Neurorestoration and Neurotechnology, VA Providence, Providence, RI, USA
- Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA
- COBRE Center for Neuromodulation, Butler Hospital, Providence, RI, USA
| | - Stephanie R Jones
- VA RR&D Center for Neurorestoration and Neurotechnology, VA Providence, Providence, RI, USA.
- Department of Neuroscience, Brown University, Providence, RI, USA.
- Carney Institute for Brain Science, Brown University, Providence, RI, USA.
| |
Collapse
|
2
|
Sulpizio V, Berchicci M, Di Russo F, Galati G, Grasso MG, Iosa M, Lucci G, Paolucci S, Ripani M, Pitzalis S. Effect of Exoskeleton-Assisted Rehabilitation Over Prefrontal Cortex in Multiple Sclerosis Patients: A Neuroimaging Pilot Study. Brain Topogr 2021; 34:651-663. [PMID: 34181126 PMCID: PMC8384810 DOI: 10.1007/s10548-021-00858-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2021] [Accepted: 06/13/2021] [Indexed: 01/05/2023]
Abstract
Application of a passive and fully articulated exoskeleton, called Human Body Posturizer (HBP), has been demonstrated to improve mobility, response accuracy and ambulation in multiple sclerosis (MS) patients. By using functional magnetic imaging (fMRI) during a visuomotor discrimination task, we performed a pilot study to evaluate the effect of HBP over the neural correlates of motor and cognitive functions which are typically impaired in MS patients. Specifically, we tested the effect of a 6-week multidisciplinary rehabilitation intervention on two groups of MS patients: a control group who followed a standard physiotherapeutic rehabilitation protocol, and an experimental group who used the HBP during physical exercises in addition to the standard protocol. We found that, after treatment, the experimental group exhibited a significant lower activity (as compared to the control group) in the inferior frontal gyrus. This post-treatment activity reduction can be explained as a retour to a normal range, being the amount of iFg activity observed in the experimental patients very similar to that observed in healthy subjects. These findings indicate that the use of HBP during rehabilitation intervention normalizes the prefrontal activity, mitigating the cortical hyperactivity associated to MS.
Collapse
Affiliation(s)
- V Sulpizio
- Department of Cognitive and Motor Rehabilitation and Neuroimaging, Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), Rome, Italy. .,Department of Psychology, Sapienza" University of Rome, Via dei Marsi, 78, 00185, Rome, Italy.
| | - M Berchicci
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - F Di Russo
- Department of Cognitive and Motor Rehabilitation and Neuroimaging, Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), Rome, Italy.,Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - G Galati
- Department of Cognitive and Motor Rehabilitation and Neuroimaging, Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), Rome, Italy.,Department of Psychology, Sapienza" University of Rome, Via dei Marsi, 78, 00185, Rome, Italy
| | - M G Grasso
- Department of Cognitive and Motor Rehabilitation and Neuroimaging, Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), Rome, Italy
| | - M Iosa
- Department of Cognitive and Motor Rehabilitation and Neuroimaging, Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), Rome, Italy.,Department of Psychology, Sapienza" University of Rome, Via dei Marsi, 78, 00185, Rome, Italy
| | - G Lucci
- Department of Human Sciences, Marconi University, Rome, Italy
| | - S Paolucci
- Department of Cognitive and Motor Rehabilitation and Neuroimaging, Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), Rome, Italy
| | - M Ripani
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - Sabrina Pitzalis
- Department of Cognitive and Motor Rehabilitation and Neuroimaging, Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), Rome, Italy.,Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| |
Collapse
|